Hypouricemic effect and safety of febuxostat used for prevention of tumor lysis syndrome

PURPOSE: We evaluated the efficacy and safety of febuxostat, a non-purine xanthine oxidase inhibitor, used for prevention of hyperuricemia associated with tumor lysis syndrome (TLS). METHODS: Records of adult patients with newly diagnosed or relapsed hematologic malignancies who received febuxostat...

Descripción completa

Detalles Bibliográficos
Autores principales: Maie, Koichiro, Yokoyama, Yasuhisa, Kurita, Naoki, Minohara, Hideto, Yanagimoto, Shintaro, Hasegawa, Yuichi, Homma, Masato, Chiba, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164671/
https://www.ncbi.nlm.nih.gov/pubmed/25279293
http://dx.doi.org/10.1186/2193-1801-3-501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4164671/
https://www.ncbi.nlm.nih.gov/pubmed/25279293
http://dx.doi.org/10.1186/2193-1801-3-501

Ejemplares similares